Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for:

LOXO ONCOLOGY-TESTING/ C
RTX5FQAB
April 03, 2018
Loxo Oncology is awaiting U.S. approval of its drug, larotrectinib, that appears to be highly effective...
Loxo Oncology&#39s quick rise EPS C
Loxo Oncology is awaiting U.S. approval of its drug, larotrectinib, that appears to be highly effective against a wide range of solid tumor cancers that share a rare genetic mutation.
Sort by
Display
Items per page
Page
of 1